Military Working Dogs (MWDs) exposed to different types of intense external stimuli, such as explosions, gunfire, or violence, may be susceptible to developing a syndrome that is similar to Posttraumatic Stress Disorder (PTSD) in people.1,2,3,4 For more information on the background of these diagnoses and the studies and manifestation of signs in humans and animals, which is beyond the scope of this guideline, there is a chapter available in the book Mental Health and Well-Being in Animals by Frank McMillan.5
In MWDs, we refer to the syndrome as Canine Posttraumatic Stress (C-PTS), or when chronic, Canine Posttraumatic Stress Disorder (C-PTSD). While much remains unknown about these syndromes in non-human animals, most of the affected MWDs to date have been exposed to these stimuli in combat scenarios. It is essential to be aware that traumatic events, or perceived traumatic events, can alter MWD behavior and veterinary personnel need to effectively guide handlers in immediate care while working to evacuate affected dogs to a veterinary facility. Veterinary Corps Officers (VCOs) are the best resource for current diagnostic and therapeutic recommendations and will facilitate telemedicine consultation with military veterinary behavior subject-matter experts. If left unrecognized and untreated, C-PTS has the potential to develop into C-PTSD, which has a lower prognosis for successful recovery and return to work than C-PTS.
Canine Posttraumatic Stress (C-PTS) - Direct involvement or exposure to a traumatic event (or perceived traumatic event) where the canine experiences life-threatening trauma, serious injury, violence (or more). Clinical signs occur acutely or within 30 days of the event.
Canine Posttraumatic Stress Disorder (C-PTSD) - Direct involvement or exposure to a traumatic event (or perceived traumatic event) where the canine experiences life-threatening trauma, serious injury, violence (or more). Clinical signs occur or persist 30 days after the event.
Canine posttraumatic stress is a diagnosis of exclusion, but an accurate history and specific behavioral and medical signs may indicate that C-PTS may be present. Providers will need to rely on the MWD handler for reporting of a traumatic event exposure and the onset of behavioral signs.
Behavioral signs will vary depending on the personality of the MWD and the perceived intensity of the traumatic event.7 They can include any combination of the following: escape or avoidance from work-related environments, increased or decreased reactivity to environmental or social stimuli, positive or negative changes in rapport with the handler, or interference with critical tasks (detection, controlled aggression, and obedience). Medical signs may include any combination of physiological responses to persistent fear, anxiety, or stress. A further description of the potential behavioral and clinical signs is provided Table 1.
NOTE: Possible delayed onset or delayed reporting of clinical signs supporting C-PTS is common, which may then fall into the category of C-PTSD.
Although MWD handlers will most likely seek guidance after acute onset of signs, providers should be aware some MWDs may not manifest obvious signs for some time, or handlers may not seek guidance until the syndrome is advanced. Additionally, some dogs will have been evaluated, and treatment initiated by veterinary personnel, from handlers seeking guidance sometime later. Thus, other keys to C-PTS for providers to be aware of are the continuance of behavioral signs for more than 30 days, resulting in the diagnosis of C-PTSD based on a failure to improve with time or treatment. The behavioral and medical signs are very similar, with the difference being persistence or progression of behavioral signs in addition to the acute versus chronic physiological stress response.
Some medical problems mimic C-PTS. Providers should carefully evaluate MWDs for exclusionary criteria, such as traumatic brain injury (see K9 TBI and Acute Neurologic Injury CPG), auditory or ocular deficits, pain or discomfort, and underlying physical disease. It is important to determine if behavioral signs were occurring before the traumatic event(s) (in other words, pre-existing fear, anxiety, or stress-related behavior) to not misdiagnose C-PTS. Providers must rule-out anecdotal reports and other appropriate behavioral diagnoses, to validate a C-PTS or C-PTSD diagnosis.
Listen to the MWD handler! If a handler seeks guidance for his or her working dog due to abnormal, inappropriate, or change in behavior in the first 30 days after a traumatic event or combat action, the following steps are recommended:
NOTE: These medications should not be stopped abruptly. If giving daily for more than two weeks, a short weaning period is indicated. Please contact a military veterinary behaviorist if you need additional guidance.
There is no role for providers to attempt long-term or delayed management of presumed C-PTSD in a deployed setting. Misdiagnosis and/or delay of appropriate treatment will equally jeopardize the affected MWD’s proper therapy and potential of return to duty. Affected dogs who are refractory to treatment of C-PTS should be evaluated under the supervision of Veterinary Corps Officers through consultation with a Veterinary Corps board-certified veterinary behaviorist. Ongoing research suggests a positive association with early diagnosis, +/- medication and focused desensitization/counterconditioning performed by the MWD handler in the early stages of case management. Every attempt is made to return the MWD to duty and avoid unnecessary STRATEVAC/redeployment, which can result in security and readiness issues.
All MWDs with documented C-PTS or C-PTSD.
Return to duty without long term medication treatment.
PERFORMANCE / ADHERENCE MEASURES
The above constitutes the minimum criteria for PI monitoring of this K9 CPG. System reporting will be performed annually; additional PI monitoring and system reporting may be performed as needed.
The system review and data analysis will be performed by direction of the K9C4 Chair.
Summary of the Joint Trauma System (JTS) Clinical Practice Guideline (CPG) for Canine Posttraumatic Stress (C-PTS) and Posttraumatic Stress Disorder (C-PTSD). This guideline supports the behavioral health of Military Working Dogs (MWDs) and Operational K9s in deployed environments.
Medical Supplies for Diagnosis, Monitoring, Exercise, and Transport
Behavioral Medication Stock
NOTE: See Table 2: MWD Medications and Dosages for Management of C-PTS and C-PTSD.
Primary medication options are available through the Joint Deployment Formulary (JDF). Adjunct medications (gabapentin and clonidine) are available through the JDF. The additional adjunct medications can be used if available at veterinary facilities.
Environmental and Behavioral Support Supplies
Exercise
See Table 3: Activity Options for Behavioral Treatment.
Documentation and Communication Tools
For additional information including National Stock Number (NSN), please contact dha.ncr.med-log.list.lpr-cps@health.mil
DISCLAIMER: This is not an exhaustive list. These are items identified to be important for the care of combat casualties.